FDA Bans PFAS Sales for US Food Packaging: A Landmark Decision

FDA Bans PFAS Sales for US Food Packaging: A Landmark Decision


X icon
Facebook icon
Link icon



The U.S. Food and Drug Administration has announced a significant development regarding the use of per- and polyfluoroalkyl substances (PFAS) in food packaging, marking a crucial step in safeguarding public health. PFAS, also known as “forever chemicals” are renowned for their persistence in the environment and are commonly used in various consumer and industrial products due to their resistance to water and grease. 

Their decision to phase-out these substances used on food packaging paper and paperboard emphasizes the growing recognition of the dangers PFAS exposure has on our health highlighting their commitment to protecting public health. 

For years concerns have been mounting over the widespread presence of PFAS in everyday products but a lack of research and regulatory mandates hindered effective regulation and action. The FDA’s decision represents a pivotal moment in efforts to protect us from the harmful effects of these persistent chemicals.

A Legacy of Contamination and Health Risks

The dangers of PFAS have been known for several decades. Research into the health and environmental effects of PFAS began in the mid-20th century, with early studies documenting their persistence in the environment and potential toxicity. By the 1970s, concerns were raised about the widespread use of PFAS and their impact on human health and the environment.

Numerous lawsuits have also drawn attention to the harmful effects and the industries responsible for their widespread use. One notable case involving PFAS contamination is the infamous “Erin Brockovich” case, where residents of Hinkley, California, were exposed to high levels of PFAS in their drinking water due to contamination from a nearby Pacific Gas and Electric Company facility.

More recent lawsuits involved the class action against 3M a major manufacturing company for their AFFF foam that was commonly used in firefighting operations. The foam was found to have PFAS and led to the contamination of waterways, negatively impacting communities that came into contact with the substance 

Voluntary Agreement by Manufacturers

Jim Jones, the deputy commissioner for human foods, emphasized the importance of the FDA’s action in ensuring consumer safety. 

The decision to prohibit PFAS in food packaging builds upon previous commitments made by manufacturers, as announced by the FDA in 2020. This forward-thinking approach underscores the agency’s dedication to staying abreast of emerging scientific findings and its proactive stance in safeguarding public health. 

The Growing Regulatory Scrutiny

In addition to the FDA’s proactive measures, growing apprehensions surround the pervasive presence of PFAS in fluorinated plastic containers. Environmental advocacy groups have accused the U.S. Environmental Protection Agency (EPA) of withholding critical test data pertaining to PFAS contamination within these containers. This is a direct violation of the agency’s obligation under the Toxic Substances Control Act and it has raised concerns about transparency and accountability in regulatory oversight.

The intricate process of fluorination employed in the manufacturing of these containers inadvertently facilitates the formation of PFAS, potentially subjecting millions of unsuspecting individuals to these harmful chemicals. 

Transparency and Accountability in Regulation

This significant development serves as a poignant reminder of the critical role that transparency and robust regulatory oversight play in confronting emerging health and environmental challenges. 

Looking ahead, sustained vigilance and concerted collaboration among regulatory agencies, manufacturers, and advocacy groups will be crucial to effectively address the multifaceted risks associated with PFAS exposure. 

Broader implications of PFAS regulation

Ongoing efforts to address contamination issues is crucial for understanding the wider impact of these measures on public health, the environment, and industry practices.

  • Protecting Public Health: PFAS contamination has been linked to numerous adverse health effects, including cancer, thyroid problems, and developmental issues. By implementing stringent regulations on PFAS use, regulatory bodies aim to protect public health and mitigate the risks associated with exposure to these harmful chemicals.
  • Addressing Environmental Concerns: PFAS are notorious for their persistence in the environment, leading to widespread contamination of water sources, soil, and wildlife. Efforts to regulate PFAS aim to prevent further environmental degradation and mitigate the long-term consequences of contamination on ecosystems and biodiversity.
  • Industry Practices and Innovation: The regulation of PFAS encourages industries to adopt alternative materials and manufacturing processes that are safer for both human health and the environment. This shift towards sustainable practices fosters innovation and drives the development of greener technologies and products.
  • Global Collaboration: PFAS contamination is a global issue that requires collaborative efforts across borders. International cooperation and information-sharing play a crucial role in addressing the transboundary nature of PFAS pollution and developing effective solutions to mitigate its impact on a global scale.
  • Consumer Awareness and Advocacy: Increased awareness of the health and environmental risks associated with PFAS contamination has spurred consumer advocacy and activism. By staying informed and actively supporting regulatory measures, consumers can play a pivotal role in driving positive change and holding industries accountable for their environmental footprint.

In conclusion, the FDA’s decisive action to ban US food packaging containing PFAS marks a significant milestone in safeguarding public health. However, the broader implications of PFAS regulation extend beyond food packaging, highlighting the need for continued vigilance and collaboration among regulatory bodies, manufacturers, and advocacy groups. 

Through collective efforts and transparency, we can mitigate the risks posed by PFAS exposure and ensure the safety of consumer products for generations to come.

De La Rosa Law, established by Oscar De La Rosa, Esq. in 2019, stands as a prominent mass tort and class action law firm committed to delivering exceptional legal services. Our distinguished team comprises professionals with expertise in law, data science, and legal technology development, reflecting our commitment to innovation and excellence.

Our dedicated team works tirelessly to provide our clients with the legal representation they deserve. De La Rosa Law specializes in data breaches, cybersecurity issues, and consumer product disputes.

If you want to know more about who we are and the impact we make, we invite you to read Our Story.